BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31608063)

  • 1. WASp Is Essential for Effector-to-Memory conversion and for Maintenance of CD8
    Liu Q; Zhang L; Shu Z; Yu T; Zhou L; Song W; Zhao X
    Front Immunol; 2019; 10():2262. PubMed ID: 31608063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency.
    Lang PA; Shaabani N; Borkens S; Honke N; Scheu S; Booth S; Brenner D; Meryk A; Barthuber C; Recher M; Mak TW; Ohashi PS; Häussinger D; Griffiths GM; Thrasher AJ; Bouma G; Lang KS
    J Allergy Clin Immunol; 2013 Mar; 131(3):815-24. PubMed ID: 23141740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mcl-1 regulates effector and memory CD8 T-cell differentiation during acute viral infection.
    Kim EH; Neldner B; Gui J; Craig RW; Suresh M
    Virology; 2016 Mar; 490():75-82. PubMed ID: 26855329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxO1 controls effector-to-memory transition and maintenance of functional CD8 T cell memory.
    Tejera MM; Kim EH; Sullivan JA; Plisch EH; Suresh M
    J Immunol; 2013 Jul; 191(1):187-99. PubMed ID: 23733882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88.
    Rahman AH; Zhang R; Blosser CD; Hou B; Defranco AL; Maltzman JS; Wherry EJ; Turka LA
    Blood; 2011 Mar; 117(11):3123-30. PubMed ID: 21233312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Snell LM; MacLeod BL; Law JC; Osokine I; Elsaesser HJ; Hezaveh K; Dickson RJ; Gavin MA; Guidos CJ; McGaha TL; Brooks DG
    Immunity; 2018 Oct; 49(4):678-694.e5. PubMed ID: 30314757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity.
    Boudousquié C; Danilo M; Pousse L; Jeevan-Raj B; Angelov GS; Chennupati V; Zehn D; Held W
    J Immunol; 2014 Sep; 193(6):2784-91. PubMed ID: 25127860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8(+) memory T-cell survival.
    Giardino Torchia ML; Munitic I; Castro E; Herz J; McGavern DB; Ashwell JD
    Eur J Immunol; 2015 Sep; 45(9):2672-82. PubMed ID: 26096449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells.
    Badovinac VP; Messingham KA; Griffith TS; Harty JT
    J Immunol; 2006 Jul; 177(2):999-1006. PubMed ID: 16818756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory.
    Singh A; Suresh M
    J Leukoc Biol; 2007 Nov; 82(5):1201-11. PubMed ID: 17704295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus.
    Grujic M; Bartholdy C; Remy M; Pinschewer DD; Christensen JP; Thomsen AR
    J Immunol; 2010 Aug; 185(3):1730-43. PubMed ID: 20601595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor c-Myb regulates CD8
    Gautam S; Fioravanti J; Zhu W; Le Gall JB; Brohawn P; Lacey NE; Hu J; Hocker JD; Hawk NV; Kapoor V; Telford WG; Gurusamy D; Yu Z; Bhandoola A; Xue HH; Roychoudhuri R; Higgs BW; Restifo NP; Bender TP; Ji Y; Gattinoni L
    Nat Immunol; 2019 Mar; 20(3):337-349. PubMed ID: 30778251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitatively different memory CD8+ T cells are generated after lymphocytic choriomeningitis virus and influenza virus infections.
    Mueller SN; Langley WA; Li G; García-Sastre A; Webby RJ; Ahmed R
    J Immunol; 2010 Aug; 185(4):2182-90. PubMed ID: 20639484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection.
    Decman V; Laidlaw BJ; Dimenna LJ; Abdulla S; Mozdzanowska K; Erikson J; Ertl HC; Wherry EJ
    J Immunol; 2010 May; 184(9):5151-9. PubMed ID: 20368274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-17~92 regulates effector and memory CD8 T-cell fates by modulating proliferation in response to infections.
    Khan AA; Penny LA; Yuzefpolskiy Y; Sarkar S; Kalia V
    Blood; 2013 May; 121(22):4473-83. PubMed ID: 23596046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion.
    Utzschneider DT; Legat A; Fuertes Marraco SA; Carrié L; Luescher I; Speiser DE; Zehn D
    Nat Immunol; 2013 Jun; 14(6):603-10. PubMed ID: 23644506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wiskott-Aldrich syndrome protein may be critical for CD8
    Li S; Huang J; Zhang YL; Zhu Y; An YF; Du J; Zhang ZL; Xia Y; Liu L; Wang L; Luo XH
    Cell Immunol; 2019 Apr; 338():43-50. PubMed ID: 30981413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
    D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
    Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties.
    Rutishauser RL; Martins GA; Kalachikov S; Chandele A; Parish IA; Meffre E; Jacob J; Calame K; Kaech SM
    Immunity; 2009 Aug; 31(2):296-308. PubMed ID: 19664941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8+ memory cell homeostasis.
    Phillips T; Opferman JT; Shah R; Liu N; Froelich CJ; Ashton-Rickardt PG
    J Immunol; 2004 Sep; 173(6):3801-9. PubMed ID: 15356127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.